NCT04400682View on ClinicalTrials.gov

Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 28, 2020

Primary Completion Date

June 5, 2020

Study Completion Date

June 18, 2020

Conditions
Bioequivalence
Interventions
DRUG

FAVIRA 200 MG Film Tablet

FAVIRA is containing 200 mg favipiravir manufactured by Novelfarma, Turkey.

DRUG

AVIGAN 200 MG Film Tablets

AVIGAN is containing 200 mg favipiravir manufactured by Toyama, Japan

Trial Locations (2)

27000

Farmagen Ar-Ge Biyot. Ltd. Sti., Şahinbey

06970

Novagenix Drug R&D Center, Akyurt

All Listed Sponsors
collaborator

Novagenix Bioanalytical Drug R&D Center

NETWORK

collaborator

Farmagen Ar-Ge Biyot. Ltd. Sti

NETWORK

lead

Novelfarma Ilaç San. ve Tic. Ltd. Sti.

INDUSTRY

NCT04400682 - Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions | Biotech Hunter | Biotech Hunter